Holds one active US DMF and one valid CEP for clonazepam, filing since 2009. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 10 markets.
Holds one active US DMF for clonazepam, filing since 2008. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds 2 active US DMFs for clonazepam, filing since 1995. Its 2022 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for clonazepam, filing since 1988. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for clonazepam, filing since 2023. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one valid CEP for clonazepam, filing since 2026. Its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free| Year | Median | Exporters |
|---|---|---|
| 2026 YTD | $1047.01 | 6 |
| 2025 | $1204.50 | 15 |
| 2024 | $1200.00 | 7 |
| 2023 | $1200.00 | 7 |
US dollars per kilogram, customs export unit values.